In 2024, urology continues to evolve with remarkable innovations. The Da Vinci SP surgical robot simplifies procedures by reducing surgical trauma and accelerating patient recovery. Regarding oncological conditions, new therapies have significantly improved the management of urological cancers, leading to increased survival rates. Additionally, for non-cancerous conditions, innovations like the Optilume balloon for urethral stricture treatment offer a minimally invasive and effective solution with few complications. These advances reflect the successful adoption of innovative technologies and targeted treatments to optimize urological care.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.53738/REVMED.2025.21.900-1.81 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Urology : what's new in 2024].
Rev Med Suisse
January 2025
Service d'urologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
In 2024, urology continues to evolve with remarkable innovations. The Da Vinci SP surgical robot simplifies procedures by reducing surgical trauma and accelerating patient recovery. Regarding oncological conditions, new therapies have significantly improved the management of urological cancers, leading to increased survival rates.
View Article and Find Full Text PDFHsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis.
Discov Oncol
November 2024
Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443002, China.
Article Synopsis
- Renal cell carcinoma (RCC) is a common and deadly cancer that shows resistance to sunitinib treatment, making it harder to treat.
- Researchers discovered a specific circular RNA (Hsa_circ_0072732) that is highly expressed in RCC cells and contributes to this resistance by influencing ferroptosis.
- The study indicates that silencing Hsa_circ_0072732 could improve RCC sensitivity to sunitinib, suggesting targeting ferroptosis could be an effective strategy for treatment.
What's in a Name? Why Words Matter in Advanced Prostate Cancer.
Eur Urol
October 2024
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Article Synopsis
- * Experts in the field gathered to discuss and improve the language surrounding this disease to make it less intimidating.
- * The goal is to establish a clearer and more accurate way to define the nomenclature related to advanced prostate cancer for better patient understanding.
Post-Vasectomy Semen Analysis: What's All the Fuss about?
Diagnostics (Basel)
October 2024
Global Andrology Forum, Moreland Hills, OH 44022, USA.
Article Synopsis
- *Societal changes have led to more younger, childless men choosing vasectomies, highlighting the need for better PVSA compliance and patient education regarding the time it takes for the procedure to become fully effective.
- *There are inconsistencies in PVSA practices, with recent developments like home testing kits raising questions about their reliability, indicating a need for standardized protocols across healthcare systems.
What's inside.
Indian J Urol
July 2024
Department of Urology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!